Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

The New England Journal of Medicine

An opinionated take on NEJM highlights for the second quarter of 2023

  • NEJM
Preparing for the next pandemic: don’t waste the value of waste During…

Read more

The New England Journal of Medicine

An opinionated take on NEJM highlights for March-April 2022

  • NEJM
The opioid crisis and patient abandonment A perspective from a Februar…

Read more

The New England Journal of Medicine

Wrapping up 2021: An opinionated take on NEJM highlights for November-December 2021

  • NEJM
In search of a diagnosis: deploying genomics at scale A substantial nu…

Read more

All immunity: an opinionated take on NEJM highlights for February 2021

  • NEJM
We can cure Hep C but not immunize against it Sovaldi and other drugs …

Read more

Closing a tough year: An opinionated take on NEJM highlights for December 2020

  • NEJM
Cardiovascular health – go big or go narrow? A follow up on the devel…

Read more

Covid, medical education, and a bit of RNAi: An opinionated take on NEJM highlights for June 2020

  • NEJM
What’s your blood type? The first report of a genome wide association…

Read more

Covid, iPSCs, and ADCs: An opinionated take on NEJM highlights for May 2020

  • NEJM
Remdesivir works… but not enough to change the public health perspecti…

Read more

Covid and the rest: An opinionated take on NEJM highlights for April 2020

  • NEJM
Hydroxychloroquine does not seem to help much in Covid-19 (with caveat…

Read more

Strategy in the Time of Covid

  • Biopharma , 
  • Payers , 
  • Providers , 
  • Medtech , 
  • Digital , 
Preamble A recent post from Recon Strategy outlined the longer-term st…

Read more

The infectiologists have the floor: An opinionated take on NEJM highlights for March 2020

  • NEJM
A first Covid-19 interventional study – unfortunately negative The fir…

Read more

Coronavirus and more: An opinionated take on NEJM highlights for January/February 2020

  • NEJM
Keeping up with COVID-19 It’s not easy for a refereed weekly print per…

Read more